Page last updated: 2024-08-16
vorinostat and ex 527
vorinostat has been researched along with ex 527 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
| Berger, W; Bouider, N; de Tullio, P; Dicato, M; Diederich, M; Goffin, E; Han, BW; Jang, JY; Ji, S; Kim, KW; Kiss, R; Lee, JY; Lefranc, F; Mathieu, V; Mazumder, A; Miklos, W; Pirotte, B; Rogister, B; Schnekenburger, M | 1 |
Other Studies
2 other study(ies) available for vorinostat and ex 527
| Article | Year |
|---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Discovery and Characterization of R/S-N-3-Cyanophenyl-N'-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines.
Topics: Antineoplastic Agents; Benzopyrans; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Drug Discovery; Drug Screening Assays, Antitumor; Histone Deacetylase Inhibitors; Humans | 2017 |